Novo Nordisk A/s

Organisation

Novo Alle 1, Bagsvaerd, Denmark, 2880

Headquarters

68794

Employees

Health Technology

Industry

Lars Fruergaard Joergensen

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides NovoPen 6 and NovoPen Echo Plus, smart insulin pens; Dose Check, an insulin dose guidance application; and growth hormone pens and injection needles. It operates in Europe, Canada, the United States, Japan, Korea, Oceania, Southeast Asia, Mainland China, Hong Kong and Taiwan, Latin America, the Middle East, and Africa. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Price

Target

Novo Nordisk A/s (NVO) Price vs Consensus Price Target

As per the chart shown above, analysts believe that the Novo Nordisk A/s (NVO) share price will touch around $47.12 in next 12-months.

Currently 32 wall-street analysts regularly analyze the financials of Novo Nordisk A/s on a frequent basis to provide recommendations along with target share price. 32 analysts offering 12-month price forecasts for Novo Nordisk A/s (NVO) have a share price target of $47.12. This median of share price forecast represents a 27.49% upside from the latest price of $36.96 as on 05.04.26.

Novo Nordisk A/s (NVO) Share Price Forecast

Home

US Stocks

Novo Nordisk A/s (NVO)

Novo Nordisk A/s Stock Forecast

Novo Nordisk A/s Stock Forecast & Price Target (Analyst Recommendation) | INDmoney

Percentage Difference

Novo Nordisk A/s (NVO): Difference between Current Price & Median Forecasted Price

Below is a chart showing the percentage difference between Novo Nordisk A/s's share price and its median forecast price. As on 05.04.26, the difference is -22.58%

Novo Nordisk A/s Forecast and Target Price

Novo Nordisk A/s (NVO) Share Price Forecast

Novo Nordisk A/s (NVO) Price vs Consensus Price Target

Novo Nordisk A/s (NVO) Share Price Forecast v/s Share Price Today

Novo Nordisk A/s (NVO): Difference between Current Price & Median Forecasted Price

Novo Nordisk A/s (NVO) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

200 Day Moving Average v/s Current Share Price